{"data":{"id":737,"lang":"en","title":"Sleep Apnea Pill Cuts Breathing Interruptions by 47% in Major European Trial, Offering CPAP Alternative","summary":"Epilepsy drug sulthiame reduced sleep apnea breathing interruptions by 47% in a 298-patient European trial, offering a pill alternative to CPAP machines.","category":"science","category_label":"Science","published_at":"2026-03-12T06:03:14Z","updated_at":"2026-03-12T06:03:14Z","url":"https://techtools.cz/tools/news/article/737-sleep-apnea-pill-cuts-breathing-interruptions-by-47-in-major-european-trial","api_url":"https://techtools.cz/news-api/v1/articles/737?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/737.md?lang=en","image_url":"https://images.squarespace-cdn.com/content/v1/6914ae344119776708eb085a/df6f9766-3a14-459a-8a4d-6add044375db/The+Global+Sleep+Apnea+Epidemic%3A+Why+1+Billion+People+May+Be+Affected","word_count":145,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260311004816.htm","domain":"sciencedaily.com"},{"url":"https://www.taylortailored.co.uk/science/the-sleep-apnea-pill-that-could-replace-cpap-new-clinical-trial-results-put-a-breakthrough-within-reach","domain":"taylortailored.co.uk"}],"translation":{"lang":"cs","id":754,"title":"Pilulka proti spánkové apnoi snížila přerušení dýchání o 47 % ve velké evropské studii a nabízí alternativu k CPAP","url":"https://techtools.cz/tools/news/clanek/754-pilulka-proti-spankove-apnoi-snizila-preruseni-dychani-o-47-ve-velke-evropske","api_url":"https://techtools.cz/news-api/v1/articles/754?lang=cs"},"content":"A major European clinical trial has found that sulthiame, an existing epilepsy drug, reduced breathing interruptions by up to 47% in patients with moderate to severe sleep apnea. The study, published in The Lancet, followed 298 participants across four countries and showed the drug also improved overnight oxygen levels with only mild, temporary side effects.\n\n\"We have been working on this treatment strategy for a long time, and the results show that sleep apnea can indeed be influenced pharmacologically. It feels like a breakthrough,\" said Jan Hedner, lead researcher at the University of Gothenburg in Sweden.\n\nThe findings could offer a pill-based alternative to CPAP machines, which many patients find uncomfortable and difficult to use consistently. Sulthiame works by stabilizing breathing control signals in the brain, reducing the upper airway collapse that causes obstructive sleep apnea — a condition affecting an estimated one billion people worldwide."}}